Cargando…
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
New oral anticoagulants (NOACs) is the preferred treatment in secondary prophylaxis of venous thromboembolic events (VTE). The aim of this study was to investigate possible risk factors associated with major bleeding in VTE-patients treated with NOACs. In this retrospective register-based study we s...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282556/ https://www.ncbi.nlm.nih.gov/pubmed/33140837 http://dx.doi.org/10.1007/s11239-020-02319-w |